ONSITE NEWSROOM
Walter E. Washington Convention Center
April 9-April 13, 2011
Phone: (202) 249-4010
media@faseb.org
Donna Krupa
Office: (301) 634-7209
dkrupa@the-aps.org
Twitter: @Phyziochick
Vitamin D May Help Heart Risk in African-Americans
Supplementation of 60,000 IU monthly improves vascular function
WASHINGTON, DC - In recent years supplementation with Vitamin D has been shown to reduce the risk of cardiovascular disease (CVD) in people who are deficient in the vitamin. Now new research from the Georgia Prevention Institute at Georgia Health Sciences University in Augusta indicates that supplementation with the "sunshine vitamin" may be particularly beneficial for overweight African-American adults, a population at increased risk for both CVD and Vitamin D deficiency.
According to Ryan A. Harris, PhD, assistant professor, the Georgia team's research suggests that Vitamin D supplementation cut the cardiovascular risk by improving the health and function of vascular endothelial cells, cells that line the inside of blood vessels. He will discuss the team's findings at the Experimental Biology 2011 meeting (EB 2011), being held April 9-13, 2011 at the Walter E. Washington Convention Center in Washington, DC. The presentation is entitled "Vitamin D Improves Flow-Mediated Dilation in African American Adults."
A Population at Risk
African-Americans as a group have multiple risk factors for CVD. They are more likely than people of other races to develop type 2 diabetes, a known contributor to CVD, and when they develop high blood pressure it tends to be more severe than that of other groups. African-Americans also have a greater risk of developing Vitamin D deficiency: The pigmentation in their skin inhibits their skin cells' ability to produce Vitamin D in response to exposure to sunlight.
The Study
In the study, 45 overweight African-American adults who were separated into two groups. (Overweight participants were chosen because carrying extra weight has been linked to inflammation in blood vessels, another risk for CVD.) One group, the treatment group, received 60,000 IU of Vitamin D in a single dose every 4 weeks for 16 weeks. The second group, the placebo group, received dummy pills. Although 60,000 IU seems like a high dose, Vitamin D has a half life of approximately 3 weeks, which means that half the dose is still in the body 3 weeks after it is taken. Given the time it takes the body to clear Vitamin D, a dose of 60,000 IU equals about 2,000 IU a day.
"We could have used daily dosing, but we knew compliance would be better with monthly dosing. One dose a month is easier than taking two pills a day," says Dr. Harris. He notes that participants reported no side effects.
At the beginning of the study, the researchers used an inflatable cuff to increase blood flow in the brachial arteries of the participants' arms, then used ultrasound to measure the arteries flow-mediated dilation. Flow-mediated dilation occurs when blood vessels dilate, or open up, in response to increased blood flow, which allows the blood to flow more freely. Vascular endothelial cells play a role in blood vessel dilation; endothelial cell dysfunction is considered to be the first sign of atherosclerosis, or "hardening of the arteries." When there is endothelial dysfunction, the blood vessels do not dilate as much and the heart has to pump harder to push blood through the vessels.
After 16 weeks, the researchers measured the participants' flow-mediated dilation again and found that flow-mediated dilation had improved in the treatment group, but not in the placebo group.
"This points to a beneficial effect of Vitamin D supplementation on endothelial cell function," says Dr. Harris. He adds that this is good news for African-Americans, given their risks for CVD. "If you're deficient in Vitamin D and you take supplements, you have a good probability of increasing endothelial function and therefore decreasing the risk of cardiovascular disease."
Exactly how Vitamin D works on the endothelial cells is the "million-dollar question" Dr. Harris says. "Vitamin D interacts with a lot of different systems in the body. It may decrease inflammation, which is better for endothelial function."
He added that more research is needed to discover the long-term effects of supplementation.
###
About Experimental Biology 2011
Experimental Biology is an annual gathering of six scientific societies that this year is expected to draw 13,000-plus independent scientists and exhibitors. The American Physiological Society (APS) is a co-sponsor of the meeting along with the American Association of Anatomists (AAA), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).
About the American Physiological Society
The American Physiological Society (APS) is a nonprofit scholarly association dedicated to fostering scientific research, education and dissemination of information about human and animal physiology. Founded in 1887 with 28 members, the APS now has more than 10,500 members, most of whom have doctoral degrees in physiology, medicine or other health sciences. The Society's national headquarters is in Bethesda, Maryland on the campus of the Federation of American Societies for Experimental Biology (FASEB).
***
NOTE TO EDITORS: To request an interview with Dr. Harris please contact Donna Krupa at 301.634.7209 or dkrupa@the-aps.org.
Predicting Risk for High Blood Pressure
Released April 26, 2010 -- There are racial differences in the activity of enzymes that make or break down a major regulator of blood pressure. New research results correlate with the bias of African Americans being more at risk for hypertension. The findings were that African American boys have more of the enzyme that makes the hormone that contributes to high blood pressure and African American girls have less of the enzyme that makes the hormone that protects against high blood pressure or hypertension.
Brown Rice and Cardiovascular Protection
Released April 26, 2010 -- Brown rice might have an advantage over white rice by offering protection from high blood pressure and atherosclerosis (“hardening of the arteries”), say researchers at Temple University School of Medicine in Philadelphia. New research suggests that a component in a layer of tissue surrounding grains of brown rice may work against angiotensin II, an endocrine protein and a known culprit in the development of high blood pressure and atherosclerosis.
Macrophages: The “Defense” Cells That Help Throughout the Body
Released August 26, 2010 - Microphages are antimicrobial warriors and play critical roles in immune regulation and wound-healing. They can respond to a variety of cellular signals and change their physiology in response to local cues. This presentation focused on how macrophages exist in nearly all tissues and are produced when white blood cells called monocytes leave the blood and differentiate in a tissue-specific manner. Immune-regulating macrophages produce high levels of the cytokine interleukin-10, which helps suppress the body’s immune response and may hold the key to developing treatments for autoimmune diseases such as multiple sclerosis or rheumatoid arthritis.
Inhaling A Heart Attack: How Air Pollution Can Cause Heart Disease
Released March 18, 2009 - Accumulating evidence indicates that an increase in particulate air pollution is associated with an increase in heart attacks and deaths. Research has begun in the relatively new field of environmental cardiology -- a field that examines the relationship between air pollution and heart disease.
"Mirthful Laughter," With Standard Diabetic Treatment, Raises Good Cholesterol, May Lower Heart Attack Risk
Released April 17, 2009 - A new study reports on the mind-emotion-disease model. “Mirthful laughter,” with standard diabetic treatment, was found to raise good cholesterol and may lower heart attack risk, according to the researchers.